Arvinas, Inc. (ARVN)
6.76
-0.06
(-0.88%)
USD |
NASDAQ |
Nov 16, 16:00
6.76
0.00 (0.00%)
After-Hours: 20:00
Arvinas Price : 6.76 for Nov. 16, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2026 | 6.88 | 6.90 | 6.615 | 6.82 | 879357.0 |
| Nov 12, 2026 | 6.85 | 6.92 | 6.62 | 6.87 | 923734.0 |
| Nov 11, 2026 | 6.93 | 6.96 | 6.74 | 6.91 | 730099.0 |
| Nov 10, 2026 | 6.57 | 6.935 | 6.49 | 6.92 | 702748.0 |
| Nov 09, 2026 | 6.52 | 6.83 | 6.33 | 6.76 | 1.040M |
| Nov 06, 2026 | 6.64 | 6.83 | 6.375 | 6.41 | 1.213M |
| Nov 05, 2026 | 7.43 | 7.435 | 6.52 | 6.55 | 1.261M |
| Nov 04, 2026 | 7.14 | 7.465 | 6.98 | 7.42 | 1.233M |
| Nov 03, 2026 | 6.91 | 7.731 | 6.79 | 7.09 | 1.802M |
| Nov 02, 2026 | 7.89 | 8.00 | 7.365 | 7.52 | 1.144M |
| Oct 30, 2026 | 7.90 | 8.03 | 7.657 | 7.86 | 1.126M |
| Oct 29, 2026 | 7.63 | 7.96 | 7.63 | 7.90 | 863795.0 |
| Oct 28, 2026 | 7.39 | 7.67 | 7.30 | 7.60 | 891608.0 |
| Oct 27, 2026 | 7.31 | 7.53 | 7.22 | 7.45 | 800825.0 |
| Oct 26, 2026 | 7.32 | 7.405 | 7.23 | 7.31 | 724862.0 |
| Oct 23, 2026 | 7.70 | 7.70 | 7.20 | 7.30 | 651573.0 |
| Oct 22, 2026 | 7.53 | 7.74 | 7.40 | 7.72 | 620197.0 |
| Oct 21, 2026 | 7.62 | 7.79 | 7.54 | 7.555 | 653596.0 |
| Oct 20, 2026 | 7.28 | 7.74 | 7.28 | 7.66 | 540851.0 |
| Oct 19, 2026 | 7.06 | 7.29 | 6.95 | 7.26 | 795637.0 |
| Oct 16, 2026 | 7.16 | 7.30 | 6.925 | 6.97 | 761289.0 |
| Oct 15, 2026 | 6.88 | 7.18 | 6.83 | 7.16 | 606046.0 |
| Oct 14, 2026 | 6.77 | 6.96 | 6.74 | 6.82 | 856960.0 |
| Oct 13, 2026 | 7.54 | 7.54 | 6.80 | 6.84 | 852894.0 |
| Oct 12, 2026 | 7.73 | 7.73 | 7.44 | 7.45 | 502649.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Cocrystal Pharma, Inc. | 0.98 |
| CNBX Pharmaceuticals, Inc. | 0.0001 |
| GB Sciences, Inc. | 0.0001 |
| Fulcrum Therapeutics, Inc. | 3.73 |
| Definium Therapeutics, Inc. | 30.14 |
Price Related Metrics
| PS Ratio | 1.596 |
| Price to Book Value | 0.8618 |
| Earnings Yield | -2.73% |
| Market Cap | 442.78M |